As of January 2025, AstraZeneca Pharma India has a market cap of $1.89B. This makes AstraZeneca Pharma India the world's 5258th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.62B | -0.29% |
2023 | $1.62B | 67.62% |
2022 | $967.99M | 6.42% |
2021 | $909.60M | -32.93% |
2020 | $1.36B | 76.53% |
2019 | $768.19M | 80.26% |
2018 | $426.17M | 24.37% |
2017 | $342.66M | 26.00% |
2016 | $271.95M | -25.77% |
2015 | $366.38M | 45.04% |
2014 | $252.60M | 2.91% |
2013 | $245.47M | -36.37% |
2012 | $385.78M | 7.53% |
2011 | $358.76M | -7.15% |
2010 | $386.37M | 39.75% |
2009 | $276.47M | 91.32% |
2008 | $144.50M | -24.95% |
2007 | $192.55M | 9.73% |
2006 | $175.48M | 17.56% |
2005 | $149.27M | 48.32% |
2004 | $100.64M | 74.30% |
2003 | $57.74M | 175.56% |
2002 | $20.95M | - |